Citation tools
"Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience." Journal of Nuclear Medicine
(2021):
jnumed.121.262240.
Web. 19 April. 2024.